Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMDA Modulation in Major Depressive Disorder in Late- Life

NCT03414931 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03414931 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMDA Modulation in Major Depressive Disorder in Late- Life
Lead sponsor
Chang Gung Memorial Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2016
Completion date
November 30, 2020
Enrollment
136 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major